BETHESDA II: Benign colloid, benign follicular nodule, lymphocytic thyroiditis, granulomatous thyroiditis | 568 | 69.4% |
BETHESDA III: Atypia of undetermined significance, follicular lesion of undetermined significance | 86 | 10.5% |
BETHESDA IV: Follicular neoplasia, hurthle cell neoplasia | 62 | 7.6% |
BETHESDA V: Carcinomas: papillary, medullary and metastatic; lymphoma | 31 | 3.8% |
BETHESDA VI: Carcinomas: papillary, medullary, anaplastic, squamous cell, mixed and metastasis | 71 | 8.7% |
Total | 818 | 100.0% |